1 Panigel M,Pascaud M,Brun JL.Radioangiographic study of circulation in the villi and intervillous space of isolated human placental cotyledon kept viable by perfusion.J Physiol (Paris),1967,59:277. 2 Schneider H,Panigel M,Dancis J.Transfer across the perfused human placenta of antipyrine,sodium and leucine.Am J Obstet Gynecol,1972,114:822-828. 3 Miller RK,Wier PJ,Maulik D,et al.Human placenta in vitro:characterization during 12 h of dual perfusion.Contrib Gynecol Obstet,1985,13:77-84. 4 Mathiesen L,Mose T,Mørck TJ,et al.Quality assessment of a placental perfusion protocol.Reprod Toxicol,2010,30:138-146. 5 Gendron MP,Martin B,Oraichi D,et al.Health care providers' requests to teratogen information services on medication use during pregnancy and lactation.Eur J Clin Pharmacol,2009,65:523-531. 6 De Sousa Mendes M,Hirt D,Vinot C,et al.Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models.Br J Clin Pharmacol,2016,81:646-657. 7 Liu XI,Momper JD,Rakhmanina N,et al.Physiologically based pharmacokinetic models to predict maternal pharmacokinetics and fetal exposure to emtricitabine and acyclovir.J Clin Pharmacol,2020,60:240-255. 8 Zheng Q,Zhou Q,Li J,et al.Placental transfer of bromocriptine in an ex vivo human placental perfusion model.J Matern Fetal Neonatal Med,2019,32:1155-1159. 9 Lee N,Hebert MF,Wagner DJ ,et al.Organic cation transporter 3 facilitates fetal exposure to metformin during pregnancy.Mol Pharmacol,2018,94:1125-1131. 10 Kurosawa K,Chiba K,Noguchi S,et al.Development of a pharmacokinetic model of transplacental transfer of metformin to predict in vivo fetal exposure.Drug Metab Dispos,2020,48:1293-1302. 11 Freriksen JJM,Schalkwijk S,Colbers AP,et al.Assessment of maternal and fetal dolutegravir exposure by integrating ex vivo placental perfusion data and physiologically-based pharmacokinetic modeling.Clin Pharmacol Ther,2020,107:1352-1361. 12 Hutson JR,Garcia-Bournissen F,Davis A,et al.The human placental perfusion model:a systematic review and development of a model to predict in vivotransfer of therapeutic drugs.Clin Pharmacol Ther,2011,90:67-76. 13 Hnat MD,Gainer J,Bawdon RE,et al.Transplacental passage of vancomycin in the ex vivo human perfusion model.Infect Dis Obstet Gynecol,2004,12:57-61. 14 Holmes HJ,Casey BM,Bawdon RE.Placental transfer of rosiglitazone in the ex vivo human perfusion model.Am J Obstet Gynecol, 2006,195:1715-1719. 15 Holcberg G,Tsadkin-Tamir M,Sapir O,et al.Transfer of insulin lispro across the human placenta.Eur J Obstet Gynecol Reprod Biol,2004,115:117-118. 16 Nathan NO,Hedegaard M,Karlsson G,et al.Intrapartum transfer of oxytocin across the human placenta:An ex vivo perfusion experiment.Placenta,2021,112:105-110. 17 Davis EF,Lazdam M,Lewandowski AJ,et al.Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies:a systematic review.Pediatrics,2012,129:e1552-e1561. 18 Hawkes N.Trial of viagra for fetal growth restriction is halted after baby deaths.BMJ,2018,362:k3247. 19 Duong A,Steinmaus C,McHale CM,et al.Reproductive and developmental toxicity of formaldehyde:a systematic review.Mutat Res,2011,728:118-138. 20 Monfared AL.Histomorphological and ultrastructural changes of the placenta in mice exposed to formaldehyde.Toxicol Ind Health,2014,30:174-181. 21 Pidoux G,Gerbaud P,Guibourdenche J,et al.Formaldehyde crosses the human placenta and affects human trophoblast differentiation and hormonal functions.Plos One,2015,10:e0133506. 22 Leppert B,Strunz S,Seiwert B et al.Maternal paraben exposure triggers childhood overweight development.Nat Commun,2020,11:561. 23 Andersen MHG,Zuri G,Knudsen LE,et al.Placental transport of parabens studied using an ex-vivo human perfusion model.Placenta,2021,115:121-128. 24 Simasotchi C,Chissey A,Jungers G,et al.A glyphosate-based formulation but not glyphosate alone alters human placental integrity.Toxics,2021,9:220. 25 Bongaerts E,Aengenheister L,Dugershaw BB,et al.Label-free detection of uptake,accumulation,and translocation of diesel exhaust particles in ex vivo perfused human placenta.J Nanobiotechnology,2021,19:144. 26 Mathiesen L,Mørck TA,Poulsen MS,et al.Placental transfer of pesticides studied in human placental perfusion.Basic Clin pharmacol Toxico,2020,127:505-515. 27 Aengenheister L,Favaro RR,Morales-Prieto DM,et al.Research on nanoparticles in human perfused placenta:State of the art and perspectives.Placenta,2021,104:199-207. 28 Jain A,Schneider H,Aliyev E,et al.Hypoxic treatment of human dual placental perfusion induces a preeclampsia-like inflammatory response.Lab Invest,2014,94:873-880. 29 Yin G,Chen M,Li J,et al.Vascular corrosion casting of normal and pre-eclamptic placentas.Exp Ther Med,2017,14:5535-5539. 30 Motta-Mejia C,Kandzija N,Zhang W,et al.Placental vesicles carry active endothelial nitric oxide synthase and their activity is reduced in preeclampsia.Hypertension,2017,70:372-381. 31 Tannetta DS,Hunt K,Jones CI,et al.Syncytiotrophoblast extracellular vesicles from pre-eclampsia placentas differentially affect platelet function.PloS One,2015,10:e0142538. 32 Reed LC,Estrada SM,Walton RB,et al.Evaluating maternal hyperglycemic exposure and fetal placental arterial dysfunction in a dual cotyledon,dual perfusion model.Placenta,2018,69:109-116. 33 Pehrson C,Mathiesen L,Heno KK,et al.Adhesion of Plasmodium falciparum infected erythrocytes in ex vivo perfused placental tissue:a novel model of placental malaria.Malaria J,2016,15:292. 34 Pehrson C,Heno KK,Adams Y,et al.Comparison of functional assays used in the clinical development of a placental malaria vaccine.Vaccine,2017,35:610-618. 35 Sedlmayr P,Blaschitz A,and Stocker R.The role of placental tryptophan catabolism.Front Immunol,2014,5:230. 36 Zardoya-Laguardia P,Blaschitz A,Hirschmugl B,et al.Endothelial indoleamine 2,3-dioxygenase-1 regulates the placental vascular tone and is deficient in intrauterine growth restriction and pre-eclampsia.Sci Rep,2018,8:5488. 37 Mills TA,Wareing M,Bugg GJ,et al.Chorionic plate artery function and Doppler indices in normal pregnancy and intrauterine growth restriction.Eur J Clin Invest,2005,35:758-764. 38 Luria O,Bar J,Barnea O,et al.Reactivity of blood vessels in response to prostaglandin E2 in placentas from pregnancies complicated by fetal growth restriction.Prenat Diagn,2012,32:417-422. 39 Dolinsky BM,Zelig CM,Paonessa DJ,et al.Effect of taurocholic acid on fetoplacental arterial pressures in a dual perfusion placental cotyledon model:a novel approach to intrahepatic cholestasis of pregnancy.J Reprod Med,2014,59:367-370. 40 Eshkoli T,Holcberg G,Bronfenmacher B,et al.Perfusion with magnesium sulfate increases sFlt-1 secretion only in the fetal side of placenta of women with preeclampsia.J Matern Fetal Neonatal Med,2013,26:116-122. 41 David AL,Torondel B,Zachary I,et al.Local delivery of VEGF adenovirus to the uterine artery increases vasorelaxation and uterine blood flow in the pregnant sheep.Gene Ther,2008,15:1344-1350. 42 Desforges M,Rogue A,Pearson N,et al.In vitro human placental studies to support adenovirus-mediated VEGF-D(ΔNΔC) maternal gene therapy for the treatment of severe early-onset fetal growth restriction.Hum Gene Ther Clin Dev,2018,29:10-23. 43 Akkermans J,van der Donk L,Peeters SHP,et al.Impact of laser power and firing angle on coagulation efficiency in laser treatment for twin-twin transfusion syndrome:an ex vivo placenta study.Fetal Diagn Ther,2017,42:204-209. 44 Al-Sowayan B,Keogh RJ,Abumaree M,et al.An ex vivo human placental vessel perfusion method to study mesenchymal stem/stromal cell migration.Stem Cell Investig,2019,6:2. 45 Warth B,Preindl K,Manser P,et al.Transfer and metabolism of the xenoestrogen zearalenone in human perfused placenta.Environ Health Perspect,2019,127:107004. 46 Mathiesen L,Bay-Richter C,Wegener G,et al.Maternal stress and placental function; ex vivo placental perfusion studying cortisol,cortisone,tryptophan and serotonin.PLoS One,2020,15:e0233979. 47 Lewis RM,Cleal JK,Sengers BG.Placental perfusion and mathematical modelling.Placenta,2020,93:43-48.
